CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
OPERATING ACTIVITIES
Net income (loss)	$ 11,688,854	$ (7,140,990)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	170,713	347,159
Noncash change in right-of-use assets	282,843	240,282
Noncash interest expense, net of interest paid	(2,923,628)	3,476,079
Share-based compensation	3,687,663	1,981,492
Gain on sale of PREBOOST business	(18,410,158)
Deferred income taxes	(2,912,778)	(198,202)
Provision for obsolete inventory	175,085	227,982
Change in fair value of derivative liabilities	2,029,000	94,000
Other	(3,000)	7,500
Changes in current assets and liabilities:
(Increase) decrease in accounts receivable	(3,083,306)	194,471
Increase in inventory	(416,867)	(1,775,018)
Increase in prepaid expenses and other assets	(9,610,334)	(4,794)
Increase in accounts payable	2,115,007	648,239
Increase in accrued expenses and other current liabilities	2,783,696	556,330
Decrease in operating lease liabilities	(337,346)	(243,514)
Net cash used in operating activities	(14,764,556)	(1,588,984)
INVESTING ACTIVITIES
Cash proceeds from sale of PREBOOST business	15,000,000
Capital expenditures	(154,416)	(73,444)
Net cash provided by (used in) investing activities	14,845,584	(73,444)
FINANCING ACTIVITIES
Proceeds from sale of shares in public offering, net of fees	108,099,988
Payment of costs related to public offering	(137,690)
Installment payments on SWK credit agreement		(3,325,180)
Proceeds from stock option exercises	1,538,147	415,464
Proceeds from premium finance agreement	1,061,442	836,780
Installment payments on premium finance agreement	(1,061,442)	(555,920)
Proceeds from sale of shares under common stock purchase agreement		13,399,999
Cash paid for debt portion of finance lease	(14,283)	(9,444)
Net cash provided by financing activities	109,486,162	10,761,699
Net increase in cash	109,567,190	9,099,271
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	13,588,778	6,295,152
CASH AND CASH EQUIVALENTS AT END OF PERIOD	123,155,968	15,394,423
Supplemental disclosure of cash flow information:
Cash paid for interest	6,651,887
Schedule of non-cash investing and financing activities:
Right-of-use assets recorded in exchange for lease liabilities		1,253,233
Notes receivable for sale of PREBOOST business	5,000,000
Amortization of deferred costs related to common stock purchase agreement		390,931
Shares issued in connection with common stock purchase agreement		680,937
Increase in other assets from accrued expenses		$ 50,284
Costs related to public offering in accrued expenses and other current liabilities	$ 20,000